ArticleInternational journal of molecular sciences2023

Changes in Metabolomic Profiles Induced by Switching from an Erythropoiesis-Stimulating Agent to a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Hemodialysis Patients: A Pilot Study.

Kimio Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.